Floatz logo

hbi0101 cart

Myasthenia Gravis (MG)

Polina StepenskyCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

21 Active assets in the Myasthenia Gravis (MG) cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
Fred Hutchinson Cancer Center
Phase 2CCC
Anti-Thymoglobulin, Rabbit
Fred Hutchinson Cancer Center
Phase 2CCC
Cytosin-Arabinosid
Fred Hutchinson Cancer Center
Phase 2CCC
ETOPOSIDE
Fred Hutchinson Cancer Center
Phase 2CCC
CARMUSTINE
Fred Hutchinson Cancer Center
Phase 2CCC

View all 22 →

Same molecule, other indications

hbi0101 cart is also rated in:

plasma cell myelomaDormant
B
Indicative ·
60 / 100
View asset →
AL amyloidosisDormant
CCC
Indicative ·
53 / 100
View asset →
plasma cell myelomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →